Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NE › Omaha › NPI 1396969499
Hospital

Alegent Health Bergan Mercy Health System

Alegent Health Bergan Mercy Health System was paid $28K by Medicaid between Jul 2021 and Apr 2023, across 8 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 60% of everything it billed.

33Billing provider infoALEGENT HEALTH BERGAN MERCY HEALTH SYSTEM
OMAHA, NE 68131
33aNPI1396969499assigned 04/12/2007
28Total paid$28K
24GClaims1,417
24DCodes billed8
24AFirst – last monthJul 2021 – Apr 2023
Compared with peers

Next to other General Acute Care Hospital providers in Nebraska

Rank by total paid#7 of 8
Median peer was paid$1.62M
This provider vs. median0.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official KUIPER, EVERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202178$0.00
2022891$21K
2023448$6K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 60% 291 264 $17K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 18% 269 242 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 18% 291 264 $5K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.6% 15 13 $992.30
81025 <1% 13 13 $44.34
J3490 Unclassified drugs 0% 156 42 $0.00
81001 0% 15 13 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 0% 367 75 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKUIPER, EVERT (CEO - CHI HEALTH)
Same official

Other billing entities under KUIPER, EVERT

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.